10 Best Growth Stocks Under $10 to Invest In

7. MeiraGTx Holdings (NASDAQ:MGTX)

MeiraGTx Holdings (NASDAQ:MGTX) is one of the best growth stocks under $10 to invest in. On April 16, MeiraGTx Holdings entered into an asset purchase agreement with Johnson & Johnson to reacquire all interests in botaretigene sparoparvovec (bota-vec), a gene therapy for X-linked retinitis pigmentosa/XLRP. Under the terms of the deal, MeiraGTx will provide an upfront cash payment of $25 million, followed by milestone payments tied to US regulatory approval and sales performance, as well as royalties starting in 2029.

The company, which is already the commercial manufacturer for the product, intends to immediately begin filing for regulatory approval in the US, EU, and Japan, targeting a potential market launch in 2027. The acquisition follows compelling data from the Phase 3 LUMEOS study, which showed clinically meaningful and statistically significant improvements in retinal sensitivity and visual function.

While the primary endpoint regarding a maze-based mobility assessment did not meet statistical significance, secondary measures showed that 45% of treated patients gained 10 or more letters in low luminance visual acuity. Furthermore, 40% of treated subjects showed improvement across multiple vision domains. MeiraGTx Holdings (NASDAQ:MGTX) plans to use its existing manufacturing infrastructure and established relationships with global centers of excellence to bring bota-vec to the estimated 20,000 patients living with XLRP in the US and Europe.

MeiraGTx Holdings (NASDAQ:MGTX) is a clinical-stage biotechnology company that develops gene therapies for serious diseases. It uses viral vector technologies to target genetic disorders, ocular diseases, and neurodegenerative conditions to deliver durable, transformative treatments.